Labshake search
Citations for Tocris :
51 - 100 of 173 citations for Pyrimidinergic Receptor P2Y4 P2RY4 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... Blocking GABAA receptors with SR 95531 hydrobromide (100 μM) (Tocris) led to over-excitability of the PN dendrites and irregular spontaneous spiking behavior ...
-
bioRxiv - Neuroscience 2022Quote: ... or the GABAB receptor blocker CGP-35348 (60 µM; Tocris). Neurons were visualized on an upright Olympus microscope (BX50WI or BX51WI ...
-
bioRxiv - Neuroscience 2023Quote: The MCH receptor antagonist SNAP-94847 hydrochloride (Tocris Bioscience, 3347) was administered IP at a dose of 20 mg/kg ...
-
bioRxiv - Neuroscience 2021Quote: ... GABA-α5 receptor inverse agonist L-655-708 (20 μM, Tocris) was bath applied in current-clamp recording to selectively block those receptor subtypes and measure effects on neuron firing properties (Drexler et al. ...
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Neuroscience 2021Quote: ... we used a metabotropic glutamate receptor agonist (L-AP4, Tocris Bioscience) to block synaptic transmission between the photoreceptors and the ON-bipolar cells ...
-
bioRxiv - Neuroscience 2019Quote: ... and CGP 52432 (selective GABAB receptor antagonist) were obtained from Tocris Bioscience (Ellisville ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 hydrobromide (Gabazine, GABAA receptor antagonist, 10 μM, Tocris Bioscience, UK) were used to block inhibitory synaptic transmission ...
-
bioRxiv - Neuroscience 2022Quote: ... the non-selective dopamine receptor antagonist Flupenthixol (15μg/.5μl/side; Tocris) or sterile saline (.5μL/side) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 500 nM of the TGFβ receptor inhibitor A83-01 (Tocris, #2939), 1x B27 supplement (ThermoFisher ...
-
bioRxiv - Neuroscience 2022Quote: ... and adrenergic α1D receptors antagonist – BMY 7378 (10 μM, Tocris 1006).
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 500 nM TGF-b type I receptor inhibitor A83-01 (Tocris), 10 µM P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.5 μM TGFb type I Receptor inhibitor A83-01 (Tocris #2939). In addition ...
-
bioRxiv - Biochemistry 2023Quote: ... 500 nM A83-01 TGF-ß type 1 receptor inhibitor (Tocris) and 10 µM SB202190 P38 MAPK inhibitor (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the NMDA receptor open-channel blocker MK-801 (Tocris, 1 mM) in the recording pipette solution ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.5 μM TGF-b type I receptor inhibitor A83-01 (Tocris Bioscience) and 1μM PGE2 (Tocris Bioscience) ...
-
bioRxiv - Neuroscience 2020Quote: ... followed by application of bicuculline (50 µM, a GABAA receptor antagonist, Tocris) for 1 min to inhibit inhibitory synaptic inputs and activate synaptic glutamate receptors ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5000 nM TGF-b type I receptor inhibitor A83-01 (Tocris #2939), 10 nM Prostaglandin E2 (Tocris #2296) ...
-
bioRxiv - Neuroscience 2023Quote: ... The selective 5-HT2C receptor antagonist RS102221 (Tocris Bioscience, #1050, Minneapolis, MN) was dissolved in a 50% aCSF and 50% sterile saline solution and infused bilaterally into the aBNST at a dose of 0.5 µg per side [14][14] ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Neuroscience 2023Quote: ... the selective D3 receptor agonist PD 128907 (PD; Tocris Bioscience, Bristol, UK) and antagonist SB 277011A (SB ...
-
bioRxiv - Neuroscience 2021Quote: ... and TCS-OX2-29 (TCS; OX2 receptor antagonist; 10 µM Tocris, Bristol, UK) were stored as 100 × concentrates at –20 ° C ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This cocktail prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... or the D1 receptor antagonist SCH 23390 hydrochloride (Tocris Bioscience, cat no: 0925) at a dose of 0.01 or 0.2 mg/kg ...
-
bioRxiv - Neuroscience 2019Quote: ... and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM; Tocris). For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM ...
-
bioRxiv - Physiology 2020Quote: ... injected with the dopamine receptor D2 (DRD2) agonist cabergoline (0.5 mg/kg, Tocris) or saline at 11:00 am ...
-
bioRxiv - Neuroscience 2021Quote: ... and glutamate receptors (NBQX, 10 μM, Tocris; and DL-AP5, 30 μM, Sigma).
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Cat# 4126, Tocris), 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2023Quote: ... The DREADD receptor was activated by intraperitoneal injection of clozapine (0.005mg/kg; Tocris) 5-10 minutes prior to the start of the experiment47,48 ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor agonist (10-5M AS-19, Tocris, CAS:1000578-26-6). The stock solutions of these drugs were diluted in extracellular physiological saline which contained ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor antagonist (10-5M Sb 258719, Tocris, CAS:1217674-10-6), 5-HT7 receptor agonist (10-5M AS-19 ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDA- and GABAA- receptors was carried out by using CNQX (10 μM, Tocris), AP-5 (40 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... the GABAA receptor antagonist gabazine (SR 95531 hydrobromide, Tocris, Wiesbaden-Nordenstadt, Germany, 5 μM) was bath-applied for 60 min after having recorded a minimum of 20 min stable baseline responses ...
-
bioRxiv - Neuroscience 2020Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
All-optical interrogation of a direction selective retinal circuit by holographic wave front shapingbioRxiv - Neuroscience 2019Quote: ... and the metabotropic glutamate receptor agonist LAP4 (20 μM, catalog no 0103, Tocris Bioscience). The retina was left to rest in the dark for ~ 30-45 min ...
-
bioRxiv - Neuroscience 2020Quote: ... we also added the glutamate receptor antagonists NBQX and CPP (both 10 µM, Tocris). For current-clamp recordings with putative muscarinic receptor-mediated currents ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2024Quote: ... while block of GABAB receptors was performed by application of 25μM CGP 46381 (Tocris). The locations of each patched cell were logged and displayed in the Figures.
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247 ...
-
bioRxiv - Cell Biology 2021Quote: ... and human vasopressin type 2 receptor (V2R) with [Arg8]-vasopressin (AVP; Tocris 2935, in water). The transfected β-arrestins are of bovine origin ...
-
bioRxiv - Neuroscience 2022Quote: ... We bath-applied the following drugs: picrotoxin (PTX) (GABAA receptor antagonist, 10µM, Tocris Bioscience, #1128) and strychnine hydrochloride (Strych ...
-
bioRxiv - Neuroscience 2019Quote: ... For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM; Tocris); the D2-like antagonists sulpiride (20 µM ...
-
bioRxiv - Neuroscience 2020Quote: Designer receptor-ligand clozapine-N-oxide (CNO, Tocris Bioscience; 4936, CAS No: 34233-69-7) was dissolved in 0.9 % saline solution at a concentration of 0.1 mg/ml and administered i.p ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.